Participating Companies

As of November 30, 2021; subject to change

Allogene Therapeutics, Inc.(ALLO)
Bicycle Therapeutics plc (BCYC)
BioCryst Pharmaceuticals, Inc. (BCRX)
Blueprint Medicines Corporation (BPMC)
Cellectis S.A. (CLLS)
Compugen Ltd. (CGEN)
CTI BioPharma Corp. (CTIC)
Cue Biopharma, Inc. (CUE)
CureVac N.V. (CVAC)
eFFECTOR Therapeutics, Inc. (EFTR)
Gamida Cell Ltd. (GMDA)
HOOKIPA Pharma Inc. (HOOK)
Inhibrx, Inc. (INBX)
Iovance Biotherapeutics, Inc. (IOVA)
Kura Oncology, Inc. (KURA)
MacroGenics, Inc. (MGN)
MorphoSys AG (MOR)
NextCure, Inc. (NXTC)
Protagonist Therapeutics, Inc. (PTGX)
Prothena Corporation plc (PRTA)
Spectrum Pharmaceuticals, Inc. (SPPI)
Syros Pharmaceuticals, Inc. (SYRS)
Vor Biopharma Inc. (VOR)

Additional companies to be announced.